WARSAW, POLAND — GEODIS, a global leader in transport and logistics, has officially completed a double regulatory milestone in Poland, strengthening its cold chain infrastructure and compliance capabilities. The company has secured the renewal of its IATA CEIV Pharma certification for its air freight operations in Warsaw, and simultaneously obtained Good Distribution Practice (GDP) certification for its contract logistics site in Stryków Dobra.
This dual achievement comes amid growing demand for high-integrity, temperature-sensitive pharmaceutical distribution in Central and Eastern Europe (CEE). It ensures full compliance with international standards, such as the European Union’s GDP guidelines, verifying GEODIS' capability to maintain strict temperature management, validated processes, and robust quality management systems across the entire logistics chain.
Understanding the Dual Certifications: GDP vs. IATA CEIV Pharma
While both certifications govern pharmaceutical handling, they target different nodes of the global supply chain. Achieving compliance across both ground contract logistics and air transport allows GEODIS to offer end-to-end, GDP-compliant transportation from manufacturer storage to final airport dispatch.
Good Distribution Practice (GDP)
Scope: Ground warehouses, contract logistics facilities, and local road transport.
Key Focus: Facility sanitation, vehicle temperature mapping, equipment calibration (alarms, sensors), batch traceability, security protocols, and robust Quality Management Systems (QMS).
IATA CEIV Pharma
Scope: Air cargo terminals, airport ramp transfers, and flight transportation.
Key Focus: Maintaining the cold chain during tarmac exposure, active/passive container handling, air freight carrier validation, standardized emergency protocols, and certified airport staff training.
Stryków Dobra Facility: Expanding Ground Contract Logistics
The newly awarded GDP certification for the contract logistics site in Stryków Dobra validates the facility's adherence to the strictest European Union guidelines (2013/C 343/01) for the distribution of human medicines. The Stryków Dobra hub plays a critical role in GEODIS' domestic contract logistics network. The facility utilizes active temperature monitoring and specialized storage zones designed to handle both cold-chain (2°C to 8°C) and ambient (15°C to 25°C) pharmaceutical goods.
Warsaw Airfreight Hub: Securing the Global Air Gateway
In parallel, the renewal of the IATA CEIV Pharma credential at GEODIS' Warsaw operations reassures pharmaceutical clients that air cargo forwarding meets uniform worldwide safety, security, and quality standards. Airport tarmac transitions are historically the weakest link in pharmaceutical distribution, where product integrity can be compromised by temperature excursions. The CEIV Pharma certification ensures that GEODIS Warsaw employs validated handling processes, specialized ground support equipment, and staff trained specifically to handle high-value biologics, vaccines, and active ingredients under strict timelines.
Visualizing GEODIS' Footprint: Poland Infrastructure & Capacity
To support its healthcare clients, GEODIS has established a powerful multi-modal logistics network across Poland. The data below outlines their logistics capacity and air cargo processing power in the region:
GEODIS Logistics Profile: Poland Operations (2026 Data)
Key statistics illustrating warehouse area, transport volumes, and certified sites.
Strengthening the European Healthcare Logistics Network
The recertification in Warsaw expands GEODIS' established European healthcare logistics network. The company now runs IATA CEIV Pharma-accredited operations in 13 European countries, facilitating specialized pharmaceutical logistics services via major continental gateways.
This network includes strategic logistics hubs across Western, Northern, and Central Europe, as outlined below:
| Country | Accredited Hub Airport / Gateways | Network Significance |
|---|---|---|
| Poland | Warsaw (WAW) | Primary gateway to Central and Eastern Europe; GDP site in Stryków Dobra and dedicated pharma warehouse in Pruszków. |
| Ireland | Dublin (DUB) | Critical link for Irish biopharma clusters and export-driven global markets. |
| Germany | Frankfurt (FRA) | Central Europe's largest air cargo hub for international vaccine and API flows. |
| Netherlands & Belgium | Amsterdam (AMS), Brussels (BRU) | Key maritime-air cross-docking zones for global pharmaceutical import/export. |
| United Kingdom | London (LHR), Manchester (MAN) | Serving advanced therapies and clinical trial distribution networks. |
| Southern Europe | Milan (MXP), Madrid (MAD) | Serving Italian and Spanish pharmaceutical manufacturers and clinical trials. |
| Nordics | Stockholm (ARN), Copenhagen (CPH) | Connecting MedTech and biopharma hubs across Scandinavia. |
| Switzerland | Zurich (ZRH) | Specialized handling for Swiss-based multinational pharma headquarters. |
Earlier in July 2026, GEODIS also announced the expansion of this certified network beyond Europe, securing IATA CEIV Pharma accreditation for its major logistics facility in Hyderabad, India, one of Asia’s largest pharmaceutical manufacturing hubs. These overlapping certifications verify that the same standard operating procedures (SOPs), quality audits, and temperature-controlled standards are applied, whether a shipment is originating in Hyderabad, transit-docking in Warsaw, or being stored in Stryków Dobra.
Strategic Impact: Poland as a CEE Life Sciences Gateway
The pharmaceutical sector in Poland has seen substantial growth, driven by both domestic consumption and its role as a manufacturing base for generic medicines, biosimilars, and clinical trials. For pharmaceutical manufacturers, the availability of logistics providers with verified cold chain and quality systems is critical to reducing distribution risk and ensuring patient safety.
By expanding its GDP-certified ground logistics footprint and maintaining CEIV Pharma air cargo operations in Warsaw, GEODIS is positioning itself to capture a larger share of the CEE contract logistics market, which is valued at several billion Euros and growing. The inclusion of a dedicated pharmaceutical facility in Pruszków further demonstrates GEODIS' commitment to localized healthcare warehousing services, offering direct proximity to Warsaw and major national highway corridors.
"The pharmaceutical supply chain is exceptionally sensitive to temperature excursions and quality deviations. By combining GDP ground logistics compliance with IATA CEIV Pharma air freight validation, we provide our life science partners with structural security and peace of mind across their logistics corridors."
Summary of GEODIS Poland Pharmaceutical Capacity
- 15 Logistics Warehouses: Spanning 195,000 m² of storage across major Polish industrial zones.
- Dual Certification: GDP (Stryków Dobra) and IATA CEIV Pharma (Warsaw Airfreight).
- Pruszków Dedicated Facility: Specialized infrastructure optimized for healthcare distribution.
- 13-Nation Network: Seamless alignment with GEODIS hubs in the UK, Germany, Ireland, and beyond.
Sources & References:
1. IndexBox Research: Geodis Renews IATA CEIV Pharma Certification for Warsaw Airfreight Operations (July 2026).
2. International Air Transport Association (IATA): CEIV Pharma Certification guidelines and Center of Excellence for Independent Validators directory (2026).
3. European Medicines Agency (EMA): Guidelines on Good Distribution Practice of medicinal products for human use (2013/C 343/01).
4. GEODIS Corporate Announcements: Logistics network updates, Poland healthcare capability expansions, and Stryków Dobra GDP compliance report.
